Cureloid

Exploring how a localized P-32 radioactive patch for keloids could become accessible in the US.

View the patch treatment Contact

Analysis

The standard options still demand too much from patients.

Recurrence anxiety

Many cycle through surgery, injections, or radiation without clear expectations.

Pain and access

Weekly clinic visits and painful, repetitive injections make adherence nearly impossible.

Limited options

Treatments standard elsewhere can still be effectively invisible and inaccessible in the US.

Method

A localized radioactive patch, not another weekly injection.

Phosphorus-32 patch therapy uses beta radiation delivered directly to the scar surface. It is a standard keloid option in parts of China, but remains absent as a primary care path in the US today.

01 / BeforeRaised keloid scar

02 / DuringP-32 patch placement

03 / AfterFlattened treatment site

Founder Note

Built by a Chinese keloid patient who utilized this treatment abroad.

Cureloid began to bridge a gap. I had keloids, received the P-32 patch treatment effectively in China, and found it far more convenient than the fragmented care paths available after moving back to the US.

While the company is inactive, this site remains a canonical handoff point for patients, clinicians, and operators seeking to understand the mechanics of the treatment.

Side Project

A functional keloid doctor directory for patients.

Built independently of the P-32 patch objective. It serves as a stark database for patients to document doctor names, verified treatment regimens, and field notes from real clinical visits.

Open directory

Interested in advancing the clinical path?

Contact team@cureloid.com

This site is an informational case study. It does not provide medical advice and does not offer radioactive treatment in the US.